celecoxib has been researched along with Benign Cerebellar Neoplasms in 4 studies
Excerpt | Relevance | Reference |
---|---|---|
"Neutropenia was the main side effect of the metronomic therapy." | 5.38 | Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012) |
"Neutropenia was the main side effect of the metronomic therapy." | 1.38 | Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hauser, P | 1 |
Vancsó, I | 1 |
Pócza, T | 1 |
Schuler, D | 1 |
Garami, M | 1 |
Yang, MY | 1 |
Lee, HT | 1 |
Chen, CM | 1 |
Shen, CC | 1 |
Ma, HI | 1 |
Chen, KH | 1 |
Hsu, CC | 1 |
Song, WS | 1 |
Huang, CS | 1 |
Tsai, CC | 1 |
Kuo, CD | 1 |
Hsu, HS | 1 |
Tsai, TH | 1 |
Tsai, CY | 1 |
Woung, LC | 1 |
Chiou, SH | 1 |
Lu, KH | 1 |
Chen, YW | 1 |
Nygaard, R | 1 |
Kivivuori, SM | 1 |
4 other studies available for celecoxib and Benign Cerebellar Neoplasms
Article | Year |
---|---|
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemothera | 2013 |
Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Apoptosis; Celecoxib; Cell Line, Tumor; Cerebellar Neoplasms; | 2014 |
Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Apoptosis; Celecoxib; Cell Division; Cell Line, Tumor; Cerebel | 2010 |
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherap | 2012 |